Screener
Myriad Genetics MYGN Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Revenue | $200.4 | $195.9 |
| Cost of revenue | 62.8 | 61.7 |
| Gross profit | 137.6 | 134.2 |
| Costs and expenses: | ||
| Research and development expense | 27.1 | 27.5 |
| Sales and marketing expense | 73.6 | 69.2 |
| General and administrative expense | 62.2 | 66.5 |
| Goodwill and long-lived asset impairment charges | 5.4 | — |
Item 1. Financial Statements.
FAQ
- What is Myriad Genetics's total cost of revenue?
- Myriad Genetics (MYGN) reported total cost of revenue of $62.8M in Q1 2026.
- How has Myriad Genetics's total cost of revenue changed year-over-year?
- Myriad Genetics's total cost of revenue increased by 1.8% year-over-year, from $61.7M to $62.8M.
- What is the long-term trend for Myriad Genetics's total cost of revenue?
- Over 3 years (2022 to 2025), Myriad Genetics's total cost of revenue has grown at a 7.1% compound annual growth rate (CAGR), from $202M to $247.9M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Myriad Genetics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude